DDInter439 DDInter1082
The conjugated estrogens are noncrystalline mixtures of purified female sex hormones obtained either by its isolation from the urine of pregnant mares or by synthetic generation from vegetal material. Both of these products are later conjugated to natrium sulfate by ester bonds in order to make them more water soluble.[L5605, T475] The conjugated estrogen product contains a mix of estrogen from which about 50% is represented by estrone sulfate followed by 25% of equilin sulfate, 15% of 17-alpha-dehydroequilenin sulfate, 3% of equilenin sulfate, 5% of 17-alpha and 17-beta-dihydroequilenin sulfate, 2% of 17-alpha-estradiolsulfate and 3% of 17-beta-estradiolsulfate. It also presents a large number of unidentified molecules with weak estrogenic activity as well as non-human molecules when it is obtained
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Conjugated estrogens {u} (Compound) resembles {v} (Compound) Ethinylestradiol
Conjugated estrogens {u} (Compound) resembles {v} (Compound) Formestane
Conjugated estrogens {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Exemestane
Conjugated estrogens {u} (Compound) treats {v} (Disease) prostate cancer
Conjugated estrogens {u} (Compound) binds {v} (Gene) SLCO4A1
Conjugated estrogens {u} (Compound) upregulates {v} (Gene) HOXC6
Conjugated estrogens {u} (Compound) palliates {v} (Disease) breast cancer
Conjugated estrogens {u} (Compound) is included by {v} (Pharmacologic Class) Estrogen Receptor Agonists
Conjugated estrogens {u} (Compound) downregulates {v} (Gene) RTN2
Conjugated estrogens {u} (Compound) causes {v} (Side Effect) Amenorrhoea
Conjugated estrogens (Compound) resembles Ethinylestradiol (Compound)
Conjugated estrogens (Compound) resembles Formestane (Compound)
Conjugated estrogens may cause a moderate interaction that could exacerbate diseases when taken with Exemestane
Conjugated estrogens (Compound) treats prostate cancer (Disease)
Conjugated estrogens (Compound) binds SLCO4A1 (Gene)
Conjugated estrogens (Compound) upregulates HOXC6 (Gene)
Conjugated estrogens (Compound) palliates breast cancer (Disease)
Conjugated estrogens (Compound) is included by Estrogen Receptor Agonists (Pharmacologic Class)
Conjugated estrogens (Compound) downregulates RTN2 (Gene)
Conjugated estrogens (Compound) causes Amenorrhoea (Side Effect)